GPP
Great Point Partners Portfolio holdings
AUM
$154M
This Quarter Return
+11.92%
1 Year Return
-2.36%
3 Year Return
+169.3%
5 Year Return
+292.82%
10 Year Return
+3,519.88%
AUM
$221M
AUM Growth
+$221M
(+7.1%)
Cap. Flow
-$9.48M
Cap. Flow
% of AUM
-4.28%
Top 10 Holdings %
Top 10 Hldgs %
70.77%
Holding
43
New
13
Increased
2
Reduced
10
Closed
10
Top Buys
| 1 |
Vanda Pharmaceuticals
VNDA
|
$12.9M |
| 2 |
ADMS
Adamas Pharmaceuticals, Inc.
ADMS
|
$7.66M |
| 3 |
ARAV
Aravive, Inc. Common Stock
ARAV
|
$7.07M |
| 4 |
SCMP
Sucampo Pharmaceuticals, Inc.
SCMP
|
$7M |
| 5 |
STML
Stemline Therapeutics, Inc.
STML
|
$6.88M |
Top Sells
| 1 |
HPTX
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
|
$22.9M |
| 2 |
INFI
Infinity Pharmaceuticals, Inc.
INFI
|
$10.6M |
| 3 |
ELGX
Endologix Inc
ELGX
|
$9.94M |
| 4 |
Arrowhead Research
ARWR
|
$8.32M |
| 5 |
Theriva Biologics
TOVX
|
$5.84M |
Sector Composition
| 1 | Healthcare | 49.97% |
| 2 | Technology | 25.73% |
